C
Dynavax Technologies Corporation DVAX
$10.31 -$0.34-3.19% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 3,119.18% 23.10% 231.86% 64.16% -99.68%
Total Depreciation and Amortization 5.77% 9.84% 10.37% 17.70% 35.13%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 125.95% 54.96% 49.29% -21.06% -80.38%
Change in Net Operating Assets 392.27% -251.00% -164.77% -187.74% 111.19%
Cash from Operations 285.09% -37.46% -61.80% -160.38% -60.61%
Capital Expenditure -101.86% -287.90% -3.73% 41.62% -8.57%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 244.95% 86.77% -209.87% 107.01% 40.98%
Cash from Investing 215.43% 85.42% -216.36% 105.41% 38.60%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -20.63% -21.64% -69.59% 149.90% 1,220.92%
Repurchase of Common Stock -40,911.84% 48.35% -9.69% -64.20% --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -5,667.29% -17.30% -381.29% -36.02% 1,060.78%
Foreign Exchange rate Adjustments -300.42% 219.02% -6,300.00% -233.11% -63.49%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -455.75% 109.47% -137.22% 33.99% -222.49%